首页> 外文期刊>Current opinion in obstetrics & gynecology >Current surgical management of breast cancer.
【24h】

Current surgical management of breast cancer.

机译:当前乳腺癌的外科治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

Breast cancer surgery continues to become more conservative. Supporting this conservatism are (1) earlier diagnosis through mammographic screening, (2) an increasing role for diagnostic ultrasound and magnetic resonance imaging, (3) the further development of image-guided core-needle biopsy, and (4) the advent of sentinel lymph node biopsy as an alternative to conventional axillary dissection. For patients with duct carcinoma in situ, the addition of radiotherapy and tamoxifen to surgical excision reduces local recurrence but has not yet improved survival over the rate observed with excision alone. There may be low-risk subgroups of duct carcinoma in situ patients for whom conservative surgery alone is adequate treatment. For patients with invasive cancer, breast conservation remains underutilized. A small survival benefit from post-mastectomy adjuvant radiotherapy is offset by an increased incidence of cardiovascular mortality, a phenomenon which has not yet been demonstrated for radiotherapy following breast conservation. Sentinel lymph node biopsy represents a new standard of care for axillary lymph node staging in the large majority of breast cancer patients with high-risk duct carcinoma in situ and stage I-II invasive cancers. The procedure is feasible, accurate, and works best with a combination of blue dye and radioisotope mapping. After proper validation studies, patients with negative sentinel lymph nodes do not require axillary dissection. The prognostic significance of sentinel lymph node micrometastases identified by enhanced pathologic techniques remains a matter of debate. Prophylactic mastectomy reduces breast cancer incidence and mortality among those with a high-risk family history, and mutations of BRCA1-2, but has significant adverse psychosocial sequelae for a small and unpredictable fraction of patients and should not be undertaken lightly. Prophylactic oophorectomy should be offered to all women with BRCA1-2 mutations, especially those beyond the years of childbearing.
机译:乳腺癌手术继续变得更加保守。支持这种保守性的是:(1)通过乳房X线检查的早期诊断;(2)在诊断超声和磁共振成像中的作用日益增强;(3)图像引导的穿刺活检的进一步发展;(4)前哨的出现淋巴结活检可替代常规腋窝清扫术。对于原位导管癌患者,在手术切除中增加放疗和三苯氧胺可减少局部复发,但仍未超过单纯切除所观察到的存活率。可能存在导管癌原位患者的低风险亚组,仅通过保守手术就可对其进行适当治疗。对于浸润性癌症患者,保乳仍然未得到充分利用。乳房切除术后辅助放疗的少量生存获益被心血管死亡率的增加所抵消,这种现象尚未得到乳腺癌保护后放疗的证实。前哨淋巴结活检代表了大多数患有高危导管原位癌和I-II期浸润性癌的乳腺癌患者腋窝淋巴结分期的新护理标准。该方法是可行的,准确的,并且与蓝色染料和放射性同位素图谱的组合效果最佳。经过适当的验证研究后,前哨淋巴结阴性的患者无需进行腋窝淋巴结清扫术。通过增强的病理技术确定前哨淋巴结微转移的预后意义仍存在争议。预防性乳房切除术可降低高家族病史和BRCA1-2突变人群的乳腺癌发生率和死亡率,但对于一小部分无法预测的患者而言,其心理社会后遗症严重,因此不宜轻举妄动。应当为所有具有BRCA1-2突变的女性提供预防性卵巢切除术,尤其是那些育龄期以后的女性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号